Business
Premier Biomedical, Inc. CEO Letter -- January, 2018
Premier Biomedical, Inc. CEO Letter -- January, 2018.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n\n DALLAS, Jan. 26, 2018 (GLOBE NEWSWIRE) -- \n Greetings From The CEO And Staff At Premier Biomedical! It has been a very busy and eventful quarter, and an exceptionally fruitful year, for Premier Biomedical (OTCQB:BIEI). Finance and Stock Performance Financing secured earlier this year has enabled the company to pivot from a pure cancer R&D company (which would remain totally dependent on borrowed money) to a revenue-producing entity with all-natural topical pain relief products.Recently our stock was moved to OTC Pink from OTCQB.  What does this mean to the business?  In effect, nothing.  We will continue to be a fully reporting company with audited financial statements.  The only negative side-effect is that it may become more difficult to borrow money, but our current strategy is to become self-funding as soon as possible, and assume debt only when absolutely necessary.By continuing all financial controls, auditing and reporting, our transition back to OTCQB or other exchanges will be facilitated. Business Structure In the third quarter of 2016, faced with a high debt load and a depressed stock price, we were forced to explore options where we could quickly transition to a revenue-producing entity.Recognizing the severity of the national crisis of opioid-related drug overdose deaths, we determined that this was a potentially large market for an opioid alternative.  After extensive consideration by our technical staff, we decided that topical hemp oil products were a potential solution to address this pressing national need.Another advantage of topical hemp oil products is that they could be developed, produced and marketed in relatively short time frame in a very cost effective manner.  We also decided that our product focus would be limited to all-natural, 50-state legal, industrial hemp oil products.Very early in 2017, we launched our e-commerce website to sell our first product, a 96-hour topical hemp oil skin patch.  During the year, we grew our product line-up to a total of five topical hemp oil skin products (a 150mg, 10 ml oil-based roll-on, a 120mg, 10 ml water-based roll-on, a 150mg, 30ml spray and a 150mg, 2 oz. ointment).In the fourth quarter, we finalized an agreement with Carl Eller, President of the NFL Retired Players Association.  We hope to develop this relation...